Hinge Health, Inc. HNGE
Regular-session close
Pre-market · Nov 20, 4:23 AM ET
- YTD
- +132.72%
- 1 year
- +145.12%
5D -11.70 (-9.66%)
- Market cap
- 8.79B
- Revenue (ttm)
- 800.82M
- Profit margin
- 21.02%
- EPS (ttm)
- 3.69
- Shares out
- 68.49M
- P/E ratio
- 29.30
- Forward P/E
- 33.21
- YTD return
- +132.72%
- 1-year return
- +145.12%
- Volume
- 1.69M
- Avg volume
- 1.91M
- Open
- 115.93
- Previous close
- 114.53
- Day's range
- 107.58 – 117.35
- 52-week range
- 30.08 – 126.40
- Analysts
- Buy
- Price target
- 135.38 (+25.2%)
- Earnings date
- Feb 9, 2027
Key statistics
- 50-day average
- 105.33
- 200-day average
- 72.18
- Enterprise value
- 9.05B
- Price / sales
- 10.97
- Price / book
- 29.32
- Revenue growth
- 52.40%
- Free cash flow
- 314.28M
- Total cash
- 294.66M
- Total debt
- 33.88M
- Return on equity
- 47.59%
- Short % of float
- 7.36%
Fundamental scorecard
11 of 25 checks passed on HNGE’s reported financials
11of 25 checks passed
- Value 0 of 5
- Growth 2 of 5
- Profitability 4 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: buy
- Target (low)
- 90.00
- Target (mean)
- 135.38
- Target (high)
- 151.00
- Strong buy7
- Buy9
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 9, 2027
Expected Feb 9, 2027. Consensus EPS estimate 0.73454.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 9, 2027 | Dec 30, 2026 | 0.74 | — | — | — |
| Nov 2, 2026 | Sep 30, 2026 | 0.576 | 0.71 | +0.13 | +23.26% |
| Aug 4, 2026 | Jun 30, 2026 | 0.615 | 0.59 | -0.03 | -4.07% |
| May 5, 2026 | Mar 31, 2026 | 0.39 | 0.45 | +0.06 | +15.38% |
| Feb 10, 2026 | Dec 31, 2025 | 0.04 | 0.49 | +0.45 | +1,125.00% |
| Nov 4, 2025 | Sep 30, 2025 | 0.24 | 0.34 | +0.10 | +41.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Nov 3, 2026 | Morgan Stanley | main | Overweight | Overweight |
| Nov 3, 2026 | Truist Securities | main | Buy | Buy |
| Nov 3, 2026 | Wells Fargo | main | Overweight | Overweight |
| Nov 3, 2026 | RBC Capital | main | Outperform | Outperform |
| Nov 3, 2026 | Evercore ISI Group | main | Outperform | Outperform |
About Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- hingehealth.com
News
Hinge Health: Improving Profitability Changes My Rating (Rating Upgrade)
HNGE Stock Surges Nearly 146% YTD: Can Its Growth Story Continue?
Healthcare Stocks Overtake Tech: 5 Strong Buys Combining Growth And Value
Add These 4 Top-Performing Liquid Stocks to Maximize Returns Freedom Capital Markets Maintains Buy on Hinge Health, Raises Price Target to $135
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131
Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $145
Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $132
RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $150
Your note
Sign in to keep a note on HNGE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| 11.2 CAPITAL I PARTNERS, LLC | Beneficial Owner of more than 10% of a Class of Security | Sale | May 22, 2025 | 0 |
| ATOMICO ADVISORS IV, LTD | Beneficial Owner of more than 10% of a Class of Security | Sale | May 22, 2025 | 0 |
| BESSEMER VENTURE PARTNERS X L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | Nov 17, 2025 | 0 |
| BUDGE JAMES W. | Chief Financial Officer | Sale | Nov 9, 2026 | 256,207 |
| LESLIE KRISTINA M | Director | Sale | Aug 19, 2026 | 30,387 |
| MECKLENBURG GABRIEL M.I. | Director | Sale | Nov 10, 2026 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 6.44% | 4,411,378 | 476.91M | Sep 29, 2026 |
| Two Sigma Investments, LP | 3.74% | 2,559,509 | 276.71M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 3.67% | 2,513,093 | 271.69M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 3.64% | 2,492,160 | 269.43M | Sep 29, 2026 |
| Morgan Stanley | 3.58% | 2,453,365 | 265.23M | Sep 29, 2026 |
| 11.2 Capital Management, LLC | 3.44% | 2,354,121 | 254.50M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.16% | 1,477,067 | 159.69M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.68% | 1,151,857 | 124.53M | Sep 29, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Growth Fund | 1.61% | 1,102,500 | 119.19M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.56% | 1,065,901 | 115.23M | Jun 29, 2026 |
| OBERWEIS FUNDS-Oberweis Small-Cap Opportunities Fund | 1.07% | 735,316 | 79.50M | Jun 29, 2026 |
| Franklin Custodian Funds-FRANKLIN DYNATECH FUND | 1.02% | 700,000 | 75.68M | Jun 29, 2026 |
